Cardiotoxicity Evaluation of Tyrosine Kinase Inhibition using Human Induced Pluripotent Stem Cell-derived Healthy and Long QT Syndrome Cardiomyocytes. Archives of Clinical and Biomedical Research, v. 8, n. 2, p. 54–72, 7 Mar.2024.